NEW YORK -- A course of pills developed by Pfizer can slash the risk of being hospitalized or dying from COVID-19 by 89% if taken within three days of developing symptoms, according to results ...
In this file photo, a person walks past the Pfizer Headquarters building in the Manhattan borough of New York City, Dec. 7, 2020. automation Pfizer announced early Thursday morning that it has ...
Pfizer announced early Thursday morning that it has selected its preferred once-daily modified release formulation of danuglipron, a move that it said was a significant milestone in the obesity drug's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results